SESSION 3: Inhalation Innovation:
Advanced Tools & Technologies
Thursday • November 21, 2024 • 9:00 AM–12:00 PM • Grand Ballroom
Moderator: Richard Dalby, Ph.D.
Photothermal Nanospectroscopic Assessment of Fluticasone Propionate/Salmeterol Xinafoate/Lactose Particle Size and Co-Association in Dry Powder Inhalation Products
Dipesh Khanal
University of Sydney
University of Sydney
Linking DPI Pre-actuation Microstructure and De-agglomeration Performance using X-ray Computed Tomography and Molecular Modeling
Parmesh Gajjar
InformiX Pharma
InformiX Pharma
A Novel Air-Jet Dry Powder Insufflator for High Efficiency Aerosol Delivery to Small Animals
Mohammad Abdul Motalib Momin
Virginia Commonwealth University
Virginia Commonwealth University
Risk Mitigation of Nitrosamines in Inhaled and Nasal Products using Active Material Science Scavenger Technologies
Badre Hammond
Aptar CSP Technologies
Aptar CSP Technologies
Discover More
In-Vitro Only Bioequivalence Approach for Generic Nasal Suspensions: The Challenge & The Opportunity
Paul Martin and Ben Stafford
Intertek
Intertek
Amorphous Content in a Drug Substance: Relevance for Inhaled Products, Methods and their Validation
Mridul Majumder
M2M Pharmaceuticals
M2M Pharmaceuticals
Delivering Precision: Innovations and Best Practices in Inhaler and Nasal Spray Testing
Deborah Jones and Ben Okorodudu
Proveris Scientific Corporation
Proveris Scientific Corporation
Relvar® Ellipta Generic: Development Of Vilanterol And Fluticasone Furoate In Vitro Bioequivalent Formulations
Marco Laackmann
Harro Höfliger
Harro Höfliger
Comparison Of The In-vivo Efficacy Of 1st And 2nd Generation Synthetic Lung Surfactant (SLS) Excipient Enhanced Growth (EEG) Dry Powder Formulations And Devices
Mohammad Abdul Motalib Momin
Virginia Commonwealth University
Virginia Commonwealth University
CO-ORGANIZERS
WORKSHOP PRESENTERS
EXHIBITORS
